Hiroaki Echigo

⁶⁸Ga- and ²¹¹At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides

Kazuma Ogawa, Hiroaki Echigo, Kenji Mishiro et al. · Molecular Pharmaceutics · 2021 · 36 citations

Development of probes for radiotheranostics with albumin binding moiety to increase the therapeutic effects of astatine-211 (211At)

Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 32 citations

Medicinal Chemistry, Engineering, Radionuclide Therapy +12

Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor

Hiroaki Echigo, Masayuki Munekane, Takeshi Fuchigami et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2024 · 19 citations · Full text

Synthesis and Evaluation of a Dimeric RGD Peptide as a Preliminary Study for Radiotheranostics with Radiohalogens

Hiroaki Echigo, Kenji Mishiro, Takeshi Fuchigami et al. · Molecules · 2021 · 15 citations · Full text

Development and evaluation of a theranostic probe with RGD peptide introduced platinum complex to enable tumor-specific accumulation

Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane et al. · Bioorganic & Medicinal Chemistry · 2022 · 15 citations

Nanomedicine, Rgd Peptide, Engineering +9